Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Clinical trial NCT04673175 · TERMINATED

Trial details

NCT number: NCT04673175
Sponsor: Weill Medical College of Cornell University
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Pneumonia Hematologic Malignancy Pseudomonas Aeruginosa Infection Bacteremia Hematopoietic Stem Cell Transplant (HSCT)

Start date: 2023-01-10
Primary completion: 2025-03-16
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.